Skip to main content

In Brief This Week: Agilent Technologies, Shanghai Institute of Biological Sciences; Geneva Bioinformatics, Integromics; GATC Biotech; RayBiotech; Texas A&M University

NEW YORK (GenomeWeb News) – Agilent Technologies and the Shanghai Institute of Biological Sciences have opened their joint systems biology center in Shanghai. According to Agilent, the SIBS-Agilent Center for Systems Biology will have multiple platforms for genomics, proteomics, and metabolomics analysis and conducting biomarker identification.


Geneva Bioinformatics and Integromics said this week that they have integrated Geneva Bioinformatics' Phenyx software platform for mass spectrometry data analysis into Integromics' OmicsHub Proteomics data analysis and management tool. The partners said that the combination of results would increase the accuracy of the protein identification process.


GATC Biotech, a German sequencing and bioinformatics services provider, said this week that it has expanded its services to include enrichment technologies from Agilent for use with next-generation sequencing systems, such as those offered by Roche 454 and Illumina. GATC said that it uses the Agilent SureSelect Targeted Enrichment system with the On-Array DNA Capture System.


RayBiotech this week said that it has established a Biomarker Discovery Pilot Grant program, under which it will offer RayBiotech products and services worth $10,000 to $20,000 to conduct proposed biomarker research. The firm, which makes antibody arrays for biomarker discovery, said that it will accept applications for the pilot grants through Jan. 31, 2010.


Texas A&M University on Thursday held an opening celebration for a new life sciences research facility that has been in the works since 2006.

The $100 million Interdisciplinary Life Sciences Building houses space for 30 labs and will include three research core centers, including the Laboratory for Biological Mass Spectrometry, a Micrsoscopy and Imaging Center, and an X-Ray Diffraction Laboratory. Researchers will use the facility for interdisciplinary studies in structural biology and bioinformatics.

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.